| Title |
Cost Effectiveness of Medication Adherence-Enhancing Interventions: A Systematic Review of Trial-Based Economic Evaluations
|
|---|---|
| Published in |
PharmacoEconomics, November 2013
|
| DOI | 10.1007/s40273-013-0108-8 |
| Pubmed ID | |
| Authors |
Edwin J. M. Oberjé, Reina J. A. de Kinderen, Silvia M. A. A. Evers, Cees M. J. van Woerkum, Marijn de Bruin |
| Abstract |
In light of the pressure to reduce unnecessary healthcare expenditure in the current economic climate, a systematic review that assesses evidence of cost effectiveness of adherence-enhancing interventions would be timely. |
X Demographics
The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 1 | 13% |
| India | 1 | 13% |
| Venezuela, Bolivarian Republic of | 1 | 13% |
| Spain | 1 | 13% |
| Unknown | 4 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 88% |
| Practitioners (doctors, other healthcare professionals) | 1 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 96 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 1% |
| Unknown | 95 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 22 | 23% |
| Student > Master | 15 | 16% |
| Student > Bachelor | 11 | 11% |
| Student > Ph. D. Student | 10 | 10% |
| Professor > Associate Professor | 5 | 5% |
| Other | 16 | 17% |
| Unknown | 17 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 28 | 29% |
| Pharmacology, Toxicology and Pharmaceutical Science | 13 | 14% |
| Nursing and Health Professions | 10 | 10% |
| Psychology | 9 | 9% |
| Social Sciences | 4 | 4% |
| Other | 12 | 13% |
| Unknown | 20 | 21% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 August 2020.
All research outputs
#3,072,869
of 22,729,647 outputs
Outputs from PharmacoEconomics
#284
of 1,815 outputs
Outputs of similar age
#29,531
of 212,391 outputs
Outputs of similar age from PharmacoEconomics
#3
of 22 outputs
Altmetric has tracked 22,729,647 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,815 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.6. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 212,391 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.